An age-old treatment has shown remarkable clinical cure rates for Clostridium difficile infection, achieving far better outcomes than antimicrobial therapy.
There are still major gaps in delivering effective treatments to patients suffering from multidrug-resistant tuberculosis, a report finds.
Johnson & Johnson accelerates Ebola vaccine pushSubscription
Johnson & Johnson’s pharmaceuticals unit, Janssen, will invest US$200m in accelerating and expanding production of its Ebola vaccine.
Men suffering erectile dysfunction in New Zealand are now able to buy sildenafil from specially trained pharmacists without a GP’s prescription.
A government refusal to introduce controls on the number of pharmacy students in the UK has been met with disappointment by pharmacy organisations.
Unannounced inspections of facilities providing hospital care for elderly patients in Wales have revealed serious shortfalls in medicines management.
Community pharmacists in England could help save the NHS up to £1bn a year if they were contracted to run a national minor ailments service.
The new medicine service is here to stay for the foreseeable future, according to the chief executive of the Pharmaceutical Services Negotiating Committee.
A call by an eating disorder charity for tougher controls on the sale of laxatives has been rejected by the Medicines and Healthcare products Regulatory Agency.
Medication errors common in childrenSubscription
A child is subject to a medication error every eight minutes in the United States, according to research that analysed calls to national poison hotlines.
Day Lewis Pharmacy, which has more than 220 pharmacies in the UK, is piloting a two-pharmacist model within its pharmacies in a bid to win services.
The NHS wastes at least £1bn – and possibly as much as £2.5bn – on preventable errors, many of which are related to improper use of medication, according to a report commissioned by the Department of Health.
The maximum price pharmaceutical companies can charge the NHS for branded medicines could be reduced by 25% under proposals by the Department of Health.
Scientists have developed a “photoswitchable” version of the diabetes drug glimepiride that is activated through exposure to blue light, allowing insulin release by pancreatic cells to be optically controlled.
Review recommends that valproate should not be prescribed to treat bipolar disorder or epilepsy in pregnant women or women or girls of childbearing age unless there is no alternative product.
Fight against Ebola growing stronger in LiberiaSubscription
Pharmacists in Liberia report that the fight against Ebola is gaining momentum with traditional leaders in rural villages implementing measures to stop transmission.
Researchers have found a way to utilise prostate cancer cells’ voracious appetite for copper as a weapon to kill them.
Oral delivery of faecal microbiota to eliminate Clostridium difficile infection is as successful as more invasive methods of the treatment.
A campaign to promote greater use of pharmacists to relieve mounting pressures on urgent and emergency NHS services has been launched.
A project that aims to benchmark pharmacy-related productivity in the NHS raises concerns for pharmacists.
Researchers are investigating a number of ways to combat the outbreak of Middle East respiratory syndrome coronavirus, including using existing drugs.
Creating a culture of whistleblowing for pharmacists Subscription
How do we improve the treatment of whistleblowers in the healthcare sector?
With a total of 90 representatives from Nigeria, Ghana and Cameroon at this year’s FIP congress in Thailand, Ebola was a recurrent theme.
AbbVie and Shire merger called offSubscription
Pharmacy student numbers will not be controlledSubscription
Scientists have identified key characteristics that enhance a nanoparticle’s ability to penetrate skin which could have implications for the delivery of medicines.
Visual acuity improved in the eyes of patients with macular degeneration being treated with embryonic stem cells.
Percutaneous transluminal angioplasty with stenting (PTAS) and medical therapy is linked with a higher risk of stroke than medical therapy alone.
A clinical trial has evaluated alternatives to first-line therapy efavirenz in treatment-naïve HIV-infected patients.
Emergence of HIV in humans traced to Kinshasa Subscription